|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
WO2006066174A1
(en)
|
2004-12-17 |
2006-06-22 |
Eli Lilly And Company |
Thiazolopyridinone derivates as mch receptor antagonists
|
|
KR20090064602A
(ko)
|
2006-10-16 |
2009-06-19 |
노파르티스 아게 |
단백질 키나제 억제제로서 유용한 페닐아세트아미드
|
|
EP2170871A2
(en)
|
2007-06-26 |
2010-04-07 |
GlaxoSmithKline LLC |
Processes for preparing benzimidazole thiophenes
|
|
WO2011047384A2
(en)
*
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
UY33288A
(es)
|
2010-03-25 |
2011-10-31 |
Glaxosmithkline Llc |
Derivados de indolina inhibidores de la proteina quinasa r del reticulo endoplasmatico
|
|
TWI535712B
(zh)
|
2010-08-06 |
2016-06-01 |
阿斯特捷利康公司 |
化合物
|
|
ES2658395T3
(es)
|
2012-04-04 |
2018-03-09 |
Rigel Pharmaceuticals, Inc. |
Inhibidores de proteína cinasa C y usos de los mismos
|
|
CN103420977B
(zh)
|
2012-05-16 |
2016-06-22 |
上海医药集团股份有限公司 |
具有抗肿瘤活性的乙炔衍生物
|
|
BR112014030284B1
(pt)
|
2012-07-18 |
2021-11-30 |
Sunshine Lake Pharma Co., Ltd |
Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
|
|
US8859553B2
(en)
|
2012-07-30 |
2014-10-14 |
Astar Biotech Llc |
Protein kinase inhibitors
|
|
ES2755772T3
(es)
|
2012-11-07 |
2020-04-23 |
Nerviano Medical Sciences Srl |
Pirimidinil y piridinilpirrolopiridinonas sustituidas, proceso para su preparación y su uso como inhibidores de cinasas
|
|
EP2997030B1
(en)
|
2013-05-14 |
2017-08-09 |
Nerviano Medical Sciences S.R.L. |
Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
|
|
EA029412B1
(ru)
|
2013-06-28 |
2018-03-30 |
Бейджин, Лтд. |
Конденсированные трициклические соединения мочевины в качестве ингибиторов киназы raf и/или димера киназы raf
|
|
WO2015117147A1
(en)
|
2014-02-03 |
2015-08-06 |
Quadriga Biosciences, Inc. |
Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
|
|
JP2017525727A
(ja)
|
2014-08-26 |
2017-09-07 |
アスター バイオテック リミテッド ライアビリティ カンパニー |
プロテインキナーゼ阻害剤
|
|
CN105837575B
(zh)
|
2015-01-13 |
2019-01-15 |
四川大学 |
3-乙炔基吡唑并嘧啶衍生物及其制备方法和用途
|
|
EA038421B1
(ru)
|
2015-12-30 |
2021-08-26 |
ВиПиЭс-3, ИНК. |
Соединения, ингибирующие металлоферменты
|
|
CN107513068A
(zh)
|
2016-06-16 |
2017-12-26 |
中国科学院上海药物研究所 |
一种具有fgfr抑制活性的新型化合物及其制备和应用
|
|
JP6570776B2
(ja)
|
2016-06-20 |
2019-09-04 |
テグ−キョンプク メディカル イノベーション ファウンデーション |
新規のイミダゾピリジン誘導体、その製造方法及びこれを有効成分として含有する癌の予防又は治療用医薬組成物
|
|
JP6867417B2
(ja)
|
2016-06-21 |
2021-04-28 |
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ |
キナーゼ阻害剤としてのｎ−（置換フェニル）−スルホンアミド誘導体
|
|
EP3296297A1
(en)
|
2016-09-15 |
2018-03-21 |
Centre National De La Recherche Scientifique |
Benzimidazol derivatives for treating filovirus infection
|
|
EP3548476A4
(en)
|
2016-12-02 |
2020-05-20 |
Quentis Therapeutics, Inc. |
SMALL MOLECULAR IRE1 INHIBITORS
|
|
AU2018272986A1
(en)
|
2017-05-26 |
2019-12-12 |
Ichnos Sciences SA |
Novel inhibitors of MAP4K1
|
|
WO2018222917A1
(en)
|
2017-06-01 |
2018-12-06 |
Quentis Therapeutics, Inc. |
Ire1 small molecule inhibitors
|
|
CA3074208C
(en)
|
2017-08-31 |
2023-10-03 |
Daiichi Sankyo Company, Limited |
Novel method for producing antibody-drug conjugate
|
|
IL277408B2
(en)
*
|
2018-04-05 |
2024-08-01 |
Merck Patent Gmbh |
Heteroaryl compounds as IRAK type II inhibitors and their use
|
|
WO2019196812A1
(zh)
|
2018-04-09 |
2019-10-17 |
上海科技大学 |
蛋白降解靶向化合物、其抗肿瘤应用、其中间体及中间体应用
|
|
US20210139484A1
(en)
|
2018-04-11 |
2021-05-13 |
Gossamer Bio Services, Inc. |
Dihydroisoquinoline-2(1h)-carboxamide and related compounds and their use in treating medical conditions
|
|
CN112243439A
(zh)
|
2018-06-13 |
2021-01-19 |
百济神州有限公司 |
作为hpk1抑制剂的吡咯并[2,3-b]吡啶或吡咯并[2,3-b]吡嗪及其用途
|
|
WO2020135507A1
(zh)
|
2018-12-26 |
2020-07-02 |
杭州百新生物医药科技有限公司 |
一种多取代苯氨基嘧啶衍生物及其制备方法和用途
|
|
CN111646995B
(zh)
*
|
2019-03-04 |
2023-03-21 |
四川大学 |
4-氨基-嘧啶并氮杂环-苯基脲类衍生物及其制备方法和用途
|
|
WO2020206583A1
(en)
|
2019-04-08 |
2020-10-15 |
Qilu Regor Therapeutics Inc. |
Kinase inhibitors and uses thereof
|
|
CA3152508A1
(en)
*
|
2019-08-29 |
2021-03-04 |
Hibercell, Inc. |
Perk inhibiting pyrrolopyrimidine compounds
|
|
WO2021057877A1
(zh)
*
|
2019-09-26 |
2021-04-01 |
深圳市塔吉瑞生物医药有限公司 |
取代的芳香稠合环衍生物及其组合物及用途
|
|
US20220389009A1
(en)
|
2019-10-01 |
2022-12-08 |
Goldfinch Bio, Inc. |
Substituted 1,6-naphthyridine inhibitors of cdk5
|
|
US12565481B2
(en)
|
2020-02-20 |
2026-03-03 |
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory |
6,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET
|
|
WO2021226547A2
(en)
|
2020-05-08 |
2021-11-11 |
Halia Therapeutics, Inc. |
Targeted nek7 inhibition for modulation of the nlrp3 inflammasome
|
|
CN113717156B
(zh)
|
2020-05-25 |
2023-05-09 |
南京红云生物科技有限公司 |
Egfr抑制剂、其制备方法及用途
|
|
GB202010464D0
(en)
|
2020-07-08 |
2020-08-19 |
Galapagos Nv |
Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
|